ProgramsCandidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
Musculoskeletal
JUV-161 Myotonic Dystrophy Type 1 (DM1)

 
Duchenne Muscular Dystrophy (DMD)

 
Osteoarthritis (OA)

 
New Programs*
Metabolic-Related Diseases

 
Hepatic Diseases

 
Other

 
Musculoskeletal
JUV-161 Myotonic Dystrophy Type 1 (DM1)
Candidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
 
Duchenne Muscular Dystrophy (DMD)
Candidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
 
Osteoarthritis (OA)
Candidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
 
New Programs*
Metabolic-Related Diseases
Candidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
 
Hepatic Diseases
Candidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
 
Other
Candidate IdentificationPreclinical ValidationLead OptimizationIND-Enabling StudiesPhase 1
 

*Therapeutic areas being evaluated